✦ LIBER ✦

Lysyl-tRNA synthetase: A target for mutant SOD1 toxicity in mitochondria

✍ Scribed by H. Kawamata; I. Hervias; M. Kiaei; M. King; C. Kunst; G. Manfredi

Book ID: 119326967
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 56 KB
Volume: 6
Category: Article
ISSN: 1567-7249
DOI: 10.1016/j.mito.2006.08.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A preferential role for lysyl-tRNA4 in t

A preferential role for lysyl-tRNA4 in the synthesis of diadenosine 5',5'''-P1P4-tetraphosphate by an arginyl-tRNA synthetase-lysyl-tRNA synthetase complex from rat liver

✍ Hilderman, Richard H.; Ortwerth, B. J. 📂 Article 📅 1987 🏛 American Chemical Society 🌐 English ⚖ 734 KB

Compound Heterozygosity for Loss-of-Func

Compound Heterozygosity for Loss-of-Function Lysyl-tRNA Synthetase Mutations in a Patient with Peripheral Neuropathy

✍ Heather M. McLaughlin; Reiko Sakaguchi; Cuiping Liu; Takao Igarashi; Davut Pehli 📂 Article 📅 2010 🏛 American Society of Human Genetics 🌐 English ⚖ 728 KB

Mitochondria as a target for decavanadat

Mitochondria as a target for decavanadate toxicity in Sparus aurata heart

✍ Sandra S. Soares; Carlos Gutiérrez-Merino; Manuel Aureliano 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 421 KB

Motor neuron disease: Common conformatio

Motor neuron disease: Common conformational change identified in toxic SOD1 mutants—a novel diagnostic marker for ALS?

✍ Malpass, Katy 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 101 KB

Escherichia coli LysU is a potential sur

Escherichia coli LysU is a potential surrogate for human lysyl tRNA synthetase in interactions with the C-terminal domain of HIV-1 capsid protein

✍ Boonyalai, Nonlawat ;Pullen, James R. ;Abdul Wahab, Mohd Firdaus ;Wright, Michae 📂 Article 📅 2013 🏛 Royal Society of Chemistry 🌐 English ⚖ 810 KB

Mitochondria as the target for mildronat

Mitochondria as the target for mildronate's protective effects in azidothymidine (AZT)-induced toxicity of isolated rat liver mitochondria

✍ Jolanta Pupure; Maria A. S. Fernandes; Maria S. Santos; António J. M. Moreno; Iv 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 255 KB 👁 2 views

## Abstract Previously mildronate, an aza‐butyrobetaine derivative, was shown to be a cytoprotective drug, through its mechanism of action of inhibition of carnitine palmitoyltransferase‐1, thus protecting mitochondria from long‐chain fatty acid accumulation and subsequent damage. Recently in an az